Oncternal Therapeutics Inc (ONCT)
8.66
-0.16
(-1.87%)
USD |
NASDAQ |
May 17, 16:00
8.95
+0.29
(+3.35%)
After-Hours: 20:00
Oncternal Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2011 | -648.8% |
| March 31, 2011 | -27.92% |
| December 31, 2010 | |
| September 30, 2010 | -661.7% |
| June 30, 2010 | -1.38K% |
| March 31, 2010 | 78.37% |
| December 31, 2009 | -295.8% |
| September 30, 2009 | -356.1% |
| June 30, 2009 | -294.6% |
| March 31, 2009 | -311.2% |
| December 31, 2008 | -462.6% |
| September 30, 2008 | -391.1% |
| June 30, 2008 | -440.3% |
| March 31, 2008 | -284.9% |
| December 31, 2007 | -667.2% |
| Date | Value |
|---|---|
| September 30, 2007 | -591.7% |
| June 30, 2007 | -504.8% |
| March 31, 2007 | -490.9% |
| December 31, 2006 | -102.5% |
| September 30, 2006 | -1.02K% |
| June 30, 2006 | -1.60K% |
| March 31, 2006 | -820.2% |
| December 31, 2005 | -1.21K% |
| September 30, 2005 | -1.60K% |
| June 30, 2005 | -548.4% |
| March 31, 2005 | -1.32K% |
| December 31, 2004 | -2.00K% |
| September 30, 2004 | -1.36K% |
| June 30, 2004 | -413.1% |
| March 31, 2004 | -11.19K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -122.2% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |